|
Apr 10
|
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer
|
|
Feb 20
|
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development
|
|
Feb 17
|
LifeTech Scientific And 2 More Penny Stocks With Promising Potential
|
|
Oct 10
|
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
|
|
Jul 26
|
Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
|